1521 related articles for article (PubMed ID: 31412603)
21. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR
Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766
[TBL] [Abstract][Full Text] [Related]
22. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
Weingarden AR; Vaughn BP
Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
[TBL] [Abstract][Full Text] [Related]
23. Association between intestinal microbiota and inflammatory bowel disease.
Zhang Y; Si X; Yang L; Wang H; Sun Y; Liu N
Animal Model Exp Med; 2022 Dec; 5(4):311-322. PubMed ID: 35808814
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review.
Kasapoglu M; Yadavalli R; Nawaz S; Althwanay A; AlEdani EM; Kaur H; Butt S
Cureus; 2024 May; 16(5):e60786. PubMed ID: 38779440
[TBL] [Abstract][Full Text] [Related]
25. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Verbeke KA; Boesmans L; Boets E
Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
[TBL] [Abstract][Full Text] [Related]
26. Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.
Rashed R; Valcheva R; Dieleman LA
Front Med (Lausanne); 2022; 9():887044. PubMed ID: 35783604
[TBL] [Abstract][Full Text] [Related]
27. The microbiome and inflammatory bowel disease.
Glassner KL; Abraham BP; Quigley EMM
J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease.
Pandey H; Jain D; Tang DWT; Wong SH; Lal D
Intest Res; 2024 Jan; 22(1):15-43. PubMed ID: 37935653
[TBL] [Abstract][Full Text] [Related]
29. Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights.
Sinagra E; Tomasello G; Cappello F; Leone A; Cottone M; Bellavia M; Rossi F; Facella T; Damiani P; Zeenny MN; Damiani F; Abruzzo A; Damiano G; Palumbo VD; Cocchi M; Jurjus A; Spinelli G; Lo Monte AI; Raimondo D
J Biol Regul Homeost Agents; 2013; 27(4):919-33. PubMed ID: 24382173
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
Eindor-Abarbanel A; Healey GR; Jacobson K
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota and inflammatory bowel disease: so far so gut!
Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
[TBL] [Abstract][Full Text] [Related]
32. Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
Lopez J; Grinspan A
Gastroenterol Hepatol (N Y); 2016 Jun; 12(6):374-9. PubMed ID: 27493597
[TBL] [Abstract][Full Text] [Related]
33. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?
Bringiotti R; Ierardi E; Lovero R; Losurdo G; Di Leo A; Principi M
World J Gastrointest Pathophysiol; 2014 Nov; 5(4):550-9. PubMed ID: 25400998
[TBL] [Abstract][Full Text] [Related]
34. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction.
Zhou Y; Xu ZZ; He Y; Yang Y; Liu L; Lin Q; Nie Y; Li M; Zhi F; Liu S; Amir A; González A; Tripathi A; Chen M; Wu GD; Knight R; Zhou H; Chen Y
mSystems; 2018; 3(1):. PubMed ID: 29404425
[TBL] [Abstract][Full Text] [Related]
35. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration.
Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Grimm MC
Public Health Rev; 2021; 42():1603990. PubMed ID: 34692176
[No Abstract] [Full Text] [Related]
36. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.
Hu Y; Chen Z; Xu C; Kan S; Chen D
Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169
[TBL] [Abstract][Full Text] [Related]
37. Host-microbial Cross-talk in Inflammatory Bowel Disease.
Nagao-Kitamoto H; Kamada N
Immune Netw; 2017 Feb; 17(1):1-12. PubMed ID: 28261015
[TBL] [Abstract][Full Text] [Related]
38. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
Ma Y; Yang D; Huang J; Liu K; Liu H; Wu H; Bao C
Open Life Sci; 2024; 19(1):20220821. PubMed ID: 38585636
[TBL] [Abstract][Full Text] [Related]
39. Microbiome, Metabolome and Inflammatory Bowel Disease.
Ahmed I; Roy BC; Khan SA; Septer S; Umar S
Microorganisms; 2016 Jun; 4(2):. PubMed ID: 27681914
[TBL] [Abstract][Full Text] [Related]
40. Probiotics and antibiotics in IBD.
Sokol H
Dig Dis; 2014; 32 Suppl 1():10-7. PubMed ID: 25531348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
